Mandel-Brehm Josh Insider Trading Activity (PMN)

Summary

Updated Jul 16, 2026

Mandel-Brehm Josh has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $10K.

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2025-09-11	CAMP	Camp4 Therapeutics Corp	P — Open-market purchase	6.1K	$1.65	$10K
2024-10-15	CAMP	Camp4 Therapeutics Corp	J — Other acquisition / disposition	605	—

Frequently Asked Questions

Who is Mandel-Brehm Josh?

Mandel-Brehm Josh is a corporate insider — currently tracked as Director of ProMIS Neurosciences Inc. (PMN). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Mandel-Brehm Josh submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Mandel-Brehm Josh been buying or selling stock?

Recorded transactions: 1 open-market purchases ($10K) and 0 open-market sales () across all tracked filings.

Where can I see all of Mandel-Brehm Josh's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Mandel-Brehm Josh — SEC Form 4 Insider Trading Activity